Kaiser Permanente, a US based health care company and managed care provider, sent out an email of health tips to its members with false information discouraging e-cigarette use.
The Kaiser email cites three outdated reports. The three points are akin to mainstream media fear mongering.
In response to Kaiser’s vaping propaganda:
- Experts have found that the FDA study that discovered diethylene glycol was contaminated. Also, e-cigarette liquid contains propylene glycol, an ingredient recognized as safe for human consumption by the FDA. Yes, it is an ingredient sometimes used in anti-freeze but it’s added to make it less harmful if accidentally swallowed. Additionally, e-cigarette’s have been on the market for over five years. If they contained diethylene glycol there would be mass reports of diethylene glycol poisoning. [Source]
- Stating that e-cigarettes “make quitting smoking harder” is not proven through the study. The report is incorrectly interpreted by mainstream media. The only true conclusion drawn is that needs to be further studied. [Source]
- A 2012 study that nicotine replacement therapy (NRT) such as nicotine patches, gums, sprays or lozenges, are not effective in long-term successful cessation. [Source]
Enough people are moving away from smoking analog cigarettes to vaping for the healthcare industry and states to take notice. Wells Fargo estimates sales of cigarettes will decline by 68% in the next 10 years due to the rising e-cigarette and vape industry. California, one of the 46 states involved in the tobacco Master Settlement Agreement (MSA), has already launched an extensive campaign to stop smokers from making the switch to vaping.
How does this relate to Kaiser and healthcare providers? The Centers for Disease Control and Prevention report that smoking costs the United States billions of dollars each year. Direct medical care accounted for $170 billion alone. Those billions of dollars in smoke related medical costs are at stake. Vaping reduces the number of smokers and smoke related medical costs. Additionally, the recommendations Kaiser provides benefit their relationships in the pharmaceutical industry.
It’s unfortunate when a healthcare company proves that its top priority is not their member’s health.